- Lonza Group AG Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from Roche Holding AG Call TranscriptMar 20, 2024
- Roche Holding AG Neurology Update TranscriptMar 11, 2024
- Full Year 2023 Roche Holding AG Earnings Presentation TranscriptFeb 01, 2024
- Roche Holding AG Neuroscience Update IR Event TranscriptOct 30, 2023
- Q3 2023 Roche Holding AG Corporate Sales Presentation TranscriptOct 19, 2023
- Roche Holding AG Pharma Day TranscriptSep 11, 2023
- Half Year 2023 Roche Holding AG Earnings Call TranscriptJul 27, 2023CHF272.45 (+0.54%)Earnings
- Alnylam Pharmaceuticals Inc to Discuss Collaboration with Roche TranscriptJul 24, 2023
- Roche Holding AG Virtual EHA 2023 Event: Crovalimab in Hematology and Nephrology TranscriptJun 12, 2023
- Roche Holding AG Virtual ESG Event TranscriptMay 23, 2023
- Q1 2023 Roche Holding AG Corporate Sales Call TranscriptApr 26, 2023
- Roche Holding AG Virtual Event - Update following Angiogenesis TranscriptFeb 13, 2023
- Full Year 2022 Roche Holding AG Earnings Call TranscriptFeb 02, 2023CHF273.85 (-1.99%)Earnings
- Roche Holding AG ASH Medical Congress Virtual Event TranscriptDec 14, 2022
- Q3 2022 Roche Holding AG Corporate Sales Presentation TranscriptOct 18, 2022
- Roche Holding AG Pharma Day 2022 TranscriptSep 12, 2022
- Half Year 2022 Roche Holding AG Earnings Call TranscriptJul 21, 2022CHF326.6 (-0.50%)Earnings
- Roche Holding AG Virtual Event at the 2022 ASCO Annual Meeting Focusing on the Oncology Pipeline TranscriptJun 06, 2022
- Roche Holding AG Virtual ESG Event: Access to Healthcare TranscriptMay 16, 2022
- Q1 2022 Roche Holding AG Corporate Sales Call TranscriptApr 25, 2022
- Roche Holding AG Annual Shareholders Meeting TranscriptMar 15, 2022
- Roche Holding AG Virtual Event on Key Ophthalmology Data Presented at the Angiogenesis 2022 Meeting TranscriptFeb 14, 2022
- Full Year 2021 Roche Holding AG Earnings Presentation TranscriptFeb 03, 2022
- Roche Holding AG ASH Virtual Update Event TranscriptDec 15, 2021
- Roche Holding AG Virtual Analyst Event During ESMO IO TranscriptDec 10, 2021
- Roche Holding AG Virtual Event "Digitalization Along the Value Chain" TranscriptNov 17, 2021
- Q3 2021 Roche Holding AG Corporate Sales Call TranscriptOct 20, 2021
- Roche Holding AG Pharma Day (Virtual) TranscriptSep 14, 2021
- Half Year 2021 Roche Holding AG Earnings Presentation TranscriptJul 22, 2021
- Roche Holding AG Virtual Event on Key Evrysdi Data Presented at 2021 CureSMA Annual Meeting TranscriptJun 14, 2021
- Roche Holding AG Virtual Event on Key Oncology Data Presented at 2021 ASCO Annual Meeting TranscriptJun 08, 2021
- Q1 2021 Roche Holding AG Corporate Sales Call TranscriptApr 21, 2021
- Roche Holding AG Diagnostics Investor Day (Virtual) TranscriptMar 23, 2021
- Roche Holding AG Virtual Event on Key Data Presented at the 2021 MDA Virtual Clinical & Scientific Conference TranscriptMar 19, 2021
- Roche Holding AG Virtual Event on Key Ophthalmology Data Presented at the Angiogenesis 2021 Meeting TranscriptFeb 16, 2021
- Full Year 2020 Roche Holding AG Earnings Presentation TranscriptFeb 04, 2021
- Roche Holding AG Virtual Event on Key Hematology Data Presented at ASH 2020 TranscriptDec 08, 2020
- Q3 2020 Roche Holding AG Corporate Sales Call TranscriptOct 15, 2020
- Roche Holding AG Virtual Pharma Day TranscriptSep 14, 2020
- Roche Holding AG Virtual Event on Data Presented at American Society of Retina Specialists 38th Annual Meeting TranscriptJul 27, 2020
- Half Year 2020 Roche Holding AG Earnings Call TranscriptJul 23, 2020CHF328.1 (-3.13%)Earnings
- Roche Holding AG Key Oncology Data Presented at ASCO 2020 (Virtual) TranscriptMay 29, 2020
- Roche Holding AG at UBS Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Roche Holding AG Virtual Digital Technology and Advanced Analytics Event TranscriptMay 07, 2020
- Roche Holding AG to Discuss New AAN 2020 Data Call TranscriptApr 28, 2020
- Q1 2020 Roche Holding AG Corporate Sales Call TranscriptApr 22, 2020
- Roche Holding AG Virtual Early Drug Development gRED Call TranscriptFeb 18, 2020
- Roche Holding AG Efficacy and Safety of Risdiplam in Patients with Type 2/3 Spinal Muscular Atrophy Presented at SMA Europe 2020 Call TranscriptFeb 06, 2020
- Full Year 2019 Roche Holding AG Earnings Call TranscriptJan 30, 2020CHF327.1 (+0.48%)Earnings
- Roche Holding AG, Bristol-Myers Squibb Co and PhRMA at JPMorgan Healthcare Conference - Panel Session TranscriptJan 15, 2020
- Sarepta Therapeutics Inc to Discuss Partnership with Roche Holding AG for its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy Call TranscriptDec 23, 2019
- Roche Holding AG to Discuss Key Data Presented at SABCS 2019 TranscriptDec 16, 2019
- Roche Holding AG to Discuss Key Hematology Data Presented at ASH 2019 TranscriptDec 10, 2019
- Roche Holding AG to Discuss Gazyva in Lupus Nephritis Presented at ASN/ASR 2019 TranscriptNov 12, 2019
- Roche Holding AG Virtual Early Drug Development pRED Event Call TranscriptNov 11, 2019
- Q3 2019 Roche Holding AG Corporate Sales Call TranscriptOct 16, 2019
- Roche Holding AG Pharma Day TranscriptSep 16, 2019
- Half Year 2019 Roche Holding AG Earnings Call TranscriptJul 25, 2019CHF264.35 (+0.21%)Earnings
- Roche Holding AG Analyst Event at ASCO 2019 TranscriptJun 03, 2019
- Roche Holding AG at American Academy of Neurology Annual Meeting TranscriptMay 13, 2019
- Q1 2019 Roche Holding AG Corporate Sales Call TranscriptApr 17, 2019
Roche Holding AG Virtual Event on Key Ophthalmology Data Presented at the Angiogenesis 2021 Meeting Transcript
(technical difficulty) Angiogenesis 2021 Webinar. My name is Henrik, and I'm the technical operator for today's call. Kindly note that the webinar is being recorded. (Operator Instructions)
At this time, it's my pleasure to introduce you to Karl Mahler, Head of Investor Relations and Group Planning. Karl, the stage is yours.
Yes. Thanks a lot, Henrik. I can see that you have a strong interest in the call. I think we have -- you told me, Henrik, that it will be about 250 people minimum preregistered, so high interest. Thanks for your interest in our ophthalmology franchise. I hope that you're all safe and well.
We have basically 1 hour to discuss our data, 30 minutes from our side on presentation, 30 minutes Q&A. This is a Zoom call. You can raise your hand, as Henrik explained. We will have the telephone line. I can see that we already have 5 participants raise the hand. (Operator Instructions) And of course, you also can send me an email if you want, [email protected]. Then I will read your
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)